Company Alzex Neuropharma Inc.

TRRI

US89656L1035

Investment Holding Companies

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Shell Companies

Market Closed - OTC Markets Other stock markets 07:09:59 09/05/2024 pm IST			5-day change	1st Jan Change
0.1 ^USD	0.00%		0.00%	-50.00%

2015	Trinity Resources Inc. will Change its Ticker to TRRI from TRLR.D	CI
2013	Trulan Resources Inc. to Acquire Additional Property Around its Existing IGP Iron-Gold-Platinum Project in Chile	CI

Alzex Neuropharma Inc., formerly Trinity Resources Inc., is a biopharmaceutical company. The Company is engaged in research and development targeting treatments of brain diseases. It is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimerâs Disease but can be applied to other neurological diseases due to its platform technology.

Number of employees: 11

Managers	Title	Age	Since
Robert Rosner CEO	Chief Executive Officer	59	10/12/10
Christopher Malone DFI	Director of Finance/CFO	61	01/22/01

Members of the board	Title	Age	Since
Robert Rosner CEO	Chief Executive Officer	59	10/12/10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,505,268	1,490,215 ( 99.00 %)	0	99.00 %

Trinity Resources, Inc.

8275 South Eastern Avenue Suite 200-168

89123, Las Vegas

+310-435-0435

http://trinresinc.com

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Shell Companies

	1st Jan change	Capi.
ALZEX NEUROPHARMA INC.	-50.00%	151K
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+191.37%	6.97B
SCREAMING EAGLE ACQUISITION CORP.	+5.09%	1.04B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+24.45%	814M
E7 GROUP	+11.31%	675M
ARES ACQUISITION CORPORATION II	+1.72%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M

Shell Companies